Dongsung Pharm (002210) - Total Liabilities

Latest as of June 2025: ₩107.40 Billion KRW ≈ $72.78 Million USD

Based on the latest financial reports, Dongsung Pharm (002210) has total liabilities worth ₩107.40 Billion KRW (≈ $72.78 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 002210 cash flow conversion to assess how effectively this company generates cash.

Dongsung Pharm - Total Liabilities Trend (2008–2024)

This chart illustrates how Dongsung Pharm's total liabilities have evolved over time, based on quarterly financial data. Check Dongsung Pharm asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Dongsung Pharm Competitors by Total Liabilities

The table below lists competitors of Dongsung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Oceanic Beverages Co Inc TW:1213	Taiwan	NT$126.25 Million
Mon Courtier Energie Groupe SA PA:ALMCE	France	€11.04 Million
BELLINI NAUTICA S.P.A. F:F2F	Germany	€13.09 Million
Wang-Zheng Bhd KLSE:7203	Malaysia	RM68.82 Million
HM Inwest S.A. WAR:HMI	Poland	zł157.19 Million
Voltaic Strategic Resources Ltd AU:VSR	Australia	AU$147.40K
Equus Total Return Closed Fund NYSE:EQS	USA	$4.90 Million

Liability Composition Analysis (2008–2024)

This chart breaks down Dongsung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Dongsung Pharm.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.73	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dongsung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dongsung Pharm (2008–2024)

The table below shows the annual total liabilities of Dongsung Pharm from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩96.73 Billion ≈ $65.56 Million	+28.69%
2023-12-31	₩75.17 Billion ≈ $50.94 Million	+15.84%
2022-12-31	₩64.89 Billion ≈ $43.98 Million	+11.61%
2021-12-31	₩58.14 Billion ≈ $39.40 Million	-17.84%
2020-12-31	₩70.77 Billion ≈ $47.96 Million	+14.83%
2019-12-31	₩61.63 Billion ≈ $41.77 Million	-25.49%
2018-12-31	₩82.71 Billion ≈ $56.05 Million	+38.05%
2017-12-31	₩59.91 Billion ≈ $40.60 Million	-14.12%
2016-12-31	₩69.77 Billion ≈ $47.28 Million	+8.37%
2011-12-31	₩64.38 Billion ≈ $43.63 Million	-6.30%
2010-12-31	₩68.71 Billion ≈ $46.56 Million	+14.63%
2009-12-31	₩59.94 Billion ≈ $40.62 Million	+5.62%
2008-12-31	₩56.75 Billion ≈ $38.46 Million	--

About Dongsung Pharm

KO:002210 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$16.09 Million

₩23.75 Billion KRW

Market Cap Rank

#25660 Global

#1917 in Korea

Share Price

₩973.00

Change (1 day)

+0.00%

52-Week Range

₩973.00 - ₩2780.00

All Time High

₩45800.00